Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

theguardian.com - Julia Kollewe - AstraZeneca makes surprise U-turn with £300m pharma investment in UK
AstraZeneca makes surprise U-turn with £300m pharma investment in UK
The Guardian

Britain's biggest drugmaker AstraZeneca has said it will invest £300m in the UK in a surprise U-turn after pausing large-scale projects last year. The drugmaker had pulled back projects in Britain after becoming disillusioned with the…

upi.com - Darryl Coote - Court sentences Purdue Pharma to pay $5.5B, clearing settlement path
Court sentences Purdue Pharma to pay $5.5B, clearing settlement path
UPI

April 28 (UPI) -- A federal judge on Tuesday sentenced Purdue Pharma to pay more than $5 billion in criminal penalties, clearing the way for the OxyContin maker to complete its bankruptcy settlement agreement and resolve thousands of opioid-related…

washingtonexaminer.com - Molly Parks - OxyContin maker Purdue Pharma set to dissolve after judge approves sentence
OxyContin maker Purdue Pharma set to dissolve after judge approves sentence
Washington Examiner

A federal judge sentenced OxyContin manufacturer Purdue Pharma on Tuesday, ordering the company to pay over $5 billion in criminal penalties. The pharmaceutical company will soon dissolve, as the sentencing was the last step before Purdue Pharma…

wsj.com - Jennifer Calfas - Purdue Pharma to Pay $225 Million to Justice Department
Purdue Pharma to Pay $225 Million to Justice Department
Wall Street Journal

A federal judge has sentenced OxyContin maker Purdue Pharma to pay the government $225 million, ending the government's yearslong criminal case and allowing the pharmaceutical company accused of fueling the opioid epidemic to wrap up a settlement…

cnbc.com - Elsa Ohlen - UK's biggest drugmakers see surprise profit bump, even as pharma grapples with U.S. policies
UK's biggest drugmakers see surprise profit bump, even as pharma grapples with U.S. policies
CNBC

Britain's largest drugmakers saw 2026 get off on a positive note, with AstraZeneca and GSK both reporting core earnings ahead of expectations on Wednesday The CEOs of a number of European pharma giants have recently said that Europe risks losing…

cnbc.com - Reuters - Purdue Pharma receives $5.5 billion sentence, paving way for opioid settlement
Purdue Pharma receives $5.5 billion sentence, paving way for opioid settlement
CNBC

Drew Angerer | Getty Images News | Getty Images OxyContin maker Purdue Pharma was sentenced on Tuesday to $5.5 billion in fines and penalties stemming from its 2020 guilty plea to charges of deceiving government regulators and paying kickbacks to…

nbcnews.com - Judge OKs OxyContin maker Purdue Pharma's criminal sentence, a last step before it dissolves
Judge OKs OxyContin maker Purdue Pharma's criminal sentence, a last step before it dissolves
NBC News

NEWARK, N.J. — OxyContin maker Purdue Pharma is set to be dissolved and replaced by a company focused on the public good by the week's end, as a massive legal settlement resolving thousands of lawsuits takes effect. A federal judge on…

france24.com - US opioid crisis victims testify at emotional Purdue Pharma hearing
US opioid crisis victims testify at emotional Purdue Pharma hearing
FRANCE 24

Between 1999 and 2023, around 806,000 people died from opioid overdoses in the United States, according to government data. Purdue and other opioid makers and distributors are accused of aggressively marketing prescription painkillers like…

newswire.ca - Piramal Pharma Limited Announces Results for Q4 and Full-year FY26
Piramal Pharma Limited Announces Results for Q4 and Full-year FY26
CNW

MUMBAI, India, April 28, 2026 /CNW/ -- Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), a leading global pharmaceutical, health and wellness company, today announced its standalone and consolidated results for the Fourth Quarter (Q4) and…

wcvb.com - GEOFF MULVIHILL Associated Press - OxyContin maker Purdue Pharma set to dissolve after judge approves its criminal sentence
OxyContin maker Purdue Pharma set to dissolve after judge approves its criminal sentence
WCVB

Seth Wenig People rally outside a courthouse while a hearing for Purdue Pharma takes place inside in Newark, N.J., Tuesday, April 21, 2026. (AP Photo/Seth Wenig) Updated: 8:24 PM EDT Apr 28, 2026 OxyContin maker Purdue Pharma set to dissolve after…

thehindubusinessline.com - Sun Pharma puts in place team to integrate Organon global operations
Sun Pharma puts in place team to integrate Organon global operations
BusinessLine

Days after Sun Pharmaceutical Industries announced its $ 11.75 billion deal to acquire United States-based healthcare company Organon – the Indian drugmaker is putting in place a team to oversee the integration of Organon's global…

thehindubusinessline.com - Piramal Pharma sees strong growth ahead on rising demand for cancer therapies
Piramal Pharma sees strong growth ahead on rising demand for cancer therapies
BusinessLine

India's Piramal Pharma hopes to accelerate earnings growth over the next two ​to three years, led by rising demand for complex drugs, ‌including targeted cancer therapies, a top executive said ​on Wednesday. The company, which…

marketbeat.com - HC Wainwright Predicts Weaker Earnings for BridgeBio Pharma
HC Wainwright Predicts Weaker Earnings for BridgeBio Pharma
MarketBeat

BridgeBio's Volatile Week Puts Biotech Stocks Under a Microscope BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) - Equities researchers at HC Wainwright cut their Q2 2026 earnings per share estimates for shares of BridgeBio Pharma in a research…

marketbeat.com - aTyr Pharma (ATYR) Projected to Post Earnings on Wednesday
aTyr Pharma (ATYR) Projected to Post Earnings on Wednesday
MarketBeat

aTyr Pharma (NASDAQ:ATYR - Get Free Report) will likely be announcing its Q1 2026 results before the market opens on Wednesday, May 6th. Analysts expect the company to announce earnings of ($0.16) per share for the quarter. Investors may visit the…

wvgazettemail.com - Mike Tony mtony@hdmediallc.com - Massive Miller House campaign fundraising lead draws from fossil fuel, pharma support
Massive Miller House campaign fundraising lead draws from fossil fuel, pharma support
wvgazettemail.com

Rep. Carol Miller, R-W.Va., has built a massive campaign fundraising advantage in her bid for a fifth term in the U.S. House of Representatives, driven by contributions from political action committees for health care and fossil fuel energy…

Receive a Daily briefing on Pharma Industry News

Get Started